Cited by 1,241Metabolomics and Mass Spectrometry StudiesMass Spectrometry Techniques and ApplicationsAdvanced Proteomics Techniques and Applications

Integrative analysis of multimodal mass spectrometry data in MZmine 3

Open access
Schmid, Robin, Heuckeroth, Steffen, Korf, Ansgar, Smirnov, Aleksandr, Myers, Owen, Dyrlund, Thomas S., Bushuiev, Roman, Murray, Kevin J. +34 more·2023·Nature Biotechnology

Abstract

I nnovation in mass spectrometry (MS) and the rapidly increasing throughput and sensitivity of MS instrumentation require adaptations and innovations in data processing tools. Here, we introduce MZmine 3, a scalable MS data analysis platform that supports hybrid datasets from various instrumental setups, including liquid and gas chromatography (LC and GC)–MS, ion mobility spectrometry (IMS)–MS and MS imaging. In particular, the integration of IMS–MS imaging and LC–IMS–MS datasets provides opportunities for spatial metabolomics analyses with increased annotation confidence. Over the past decade, the MZmine project has evolved into a community-driven, collaborative effort. As an open-source ecosystem for MS data processing, MZmine is a cross-platform software (Supplementary Note 1) that can be tuned for robust, scalable and reproducible data analysis on personal computers as well as high-performance supercomputers. The project has seen continuous development since its inception in 2004 (refs. ). Community additions (Fig. 1a) introduced various functions, such as performant feature detection workflows, modules for lipid annotation and strong ties to other community projects (Fig. 1b). Here, data exchange formats and direct interfaces (listed under ‘Tool integration’ in the documentation) enable downstream analysis in external tools, such as compound annotation in SIRIUS and statistical analysis in MetaboAnalyst, and directly bind MZmine results into the molecular networking ecosystem of the Global Natural Products Social Molecular Networking (GNPS) web platform (Supplementary Note 2). Recent advances in MS instrumentation push sensitivity, resolving power and data acquisition speed, resulting in increased data volume and complexity. Notably, IMS gains traction in the field by including an additional separation dimension to LC–MS or imaging-based techniques like matrix-assisted laser desorption/ionization (MALDI)–MS. These advances introduce new acquisition modes (for example, parallel accumulation–serial fragmentation (PASEF)) or enable combination of IMS and imaging, which was shown to improve annotation quality in MS imaging. Furthermore, the number of large-scale cohort and multifactorial studies in clinical, environmental and other fields is growing, as registered in the three main metabolomics data repositories: MassIVE/GNPS, MetaboLights and Metabolomics Workbench. The need for scalable, reproducible and flexible data analysis workflows that can combine MS data from various sources remains unaddressed by existing tools. For example, to combine LC–(IMS–)MS and MS imaging results from the same sample, users are forced to master multiple software tools that divide the workflow and are specialized for either chromatography–MS (for example, MS-DIAL, XCMS, OpenMS) or MS imaging (for example, METASPACE, rMSI, Cardinal MSI, SpectralAnalysis). The integrative spatial metabolomics workflow in MZmine 3 (Fig. 1c) imports LC–IMS–MS and IMS–MS imaging datasets stored in either open or vendor-specific formats and processes them by non-targeted feature detection. This entails resolving peak shapes for ion features in both the retention time (RT) and ion mobility dimension in LC–IMS–MS and extracting mobility-resolved ion image features with spatial distributions in IMS–MS imaging (Supplementary Figs. 1–3). Individual features from both methodologies are subsequently represented and aligned by their RT (LC only), m/z and ion mobility values. The resulting aligned feature list combines the strengths of the individual analytical methods by integrating the compound annotation capabilities of modern chromatography-based MS with spatial metabolite distributions that can be mapped to histological data, addressing the issue of missing MS data in most imaging studies. For data evaluation, MZmine organizes annotations in a feature table with interactive charts, exemplified in Fig. 1d for one ion feature detected in LC–IMS–MS samples and aligned to an ion image from one MALDI–IMS–MS imaging dataset. An exemplary spatial metabolomics workflow leading to LC–IMS–MS-resolved molecular networks, enriched with spatial ion feature information, is described in Supplementary Note 2 and Supplementary Fig. 4. Additional visualization modules (Supplementary Fig. 5) connect all available data dimensions; a fast memory-mapped data back end enables interactive exploration. In MZmine 3, special attention was directed toward scalability due to the ever increasing study sizes that lead to large volumes of raw data, particularly in the case of LC–IMS–MS datasets. Efficient memory management and parallelization removed bottlenecks, resulting in an 89% reduction in processing time for 250 dissolved organic matter samples when compared to MZmine 2. A stress test demonstrated high sample throughput, where the mean processing times amounted to 0.1% to 0.3% of the total data acquisition time for six different LC–MS datasets (Supplementary Note 3 and Supplementary Fig. 6). Further, MZmine 3 was benchmarked using 8,273 fecal LC–MS samples, requiring just 47 min of processing time (see hardware specifications in Supplementary Note 3). The improved performance of MZmine 3 over previous MZmine versions now allows processing of large datasets, including large-volume LC–IMS–MS data. For new users, the MZmine website contains detailed manuals and video tutorials, and the new processing wizard in MZmine provides starting points for various standard workflows and mass spectrometer types. In addition, a development tutorial is available for potential new contributors, and the modular design of MZmine enables testing and implementing of new ideas within the MZmine framework.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41587-023-01690-2

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [2]2. Pluskal, T., Castillo, S., Villar-Briones, A. & Oresic, M. BMC Bioinformatics 11, 395 (2010).
  2. [10]10. Schmid, R. et al. Nat. Commun. 12, 3832 (2021).
  3. [13]13. Aksenov, A. A., da Silva, R., Knight, R., Lopes, N. P. & Dorrestein, P. C. Nat. Rev. Chem. 1, 0054 (2017).
  4. [17]17. Weiskirchen, R., Weiskirchen, S., Kim, P. & Winkler, R. J. Cheminform. 11, 16 (2019).

Cited by

Sorted by citations

Authors
Schmid, R., Heuckeroth, S., Korf, A., Smirnov, A., Myers, O., Dyrlund, T. S., Bushuiev, R., Murray, K. J., Hoffmann, N., Lu, M., Sarvepalli, A., Zhang, Z., Fleischauer, M., Dührkop, K., Wesner, M., Hoogstra, S. J., Rudt, E., Mokshyna, O., Brungs, C., Ponomarov, K., Mutabdžija, L., Damiani, T., Pudney, C. J., Earll, M., Helmer, P. O., Fallon, T. R., Schulze, T., Rivas-Ubach, A., Bilbao, A., Richter, H., Nothias, L.-F., Wang, M., Orešič, M., Weng, J.-K., Böcker, S., Jeibmann, A., Hayen, H., Karst, U., Dorrestein, P. C., Petras, D., Du, X., & Pluskal, T.
Affiliations
  • University of Münster (DE)
  • University of North Carolina at Charlotte (US)
  • Steno Diabetes Center Copenhagen (DK)
  • Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry (CZ)
  • University of Minnesota (US)
  • Forschungszentrum Jülich (DE)
  • Westlake University (CN)
  • San Diego Supercomputer Center (US)
  • University of California San Diego (US)
  • Friedrich Schiller University Jena (DE)
  • Agriculture and Agri-Food Canada (CA)
  • Scripps Institution of Oceanography (US)
  • Helmholtz Centre for Environmental Research (DE)
  • University of Zurich (CH)
  • University of California, Riverside (US)
  • Åbo Akademi University (FI)
  • Whitehead Institute for Biomedical Research (US)
  • University Hospital Münster (DE)
  • University of Tübingen (DE)
Corresponding author
Pluskal, Tomáš
Venue
Nature Biotechnology
Published
2023-03-01
Volume
41
Issue
4
Pages
447-449
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W4322739219
Cited by
1,241
References
17
Citations by year
2026: 409 · 2025: 444 · 2024: 291 · 2023: 96 · 2022: 1
FWCI
109.54
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • Åbo Akademi University Research Portal (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • National Science Foundation (2152526, 1818132)
  • U.S. Department of Energy
  • U.S. Department of Agriculture
  • Chan Zuckerberg Initiative
  • Joint Genome Institute
  • European Commission (HORIZON2020, 891397)
  • Deutsche Forschungsgemeinschaft (EXC 2124, BO 1910/20, TRR261, 390838134, 398967434, 441958208)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (NIH U19, 189921)
  • Grantová Agentura České Republiky (GM21-11563M)
  • Novo Nordisk Fonden (NNF16SA0024126-3)
  • National Institutes of Health
  • Office of Science
  • Biotechnology and Biological Sciences Research Council (2152526)
  • National Institute on Aging (U19AG063744)
  • National Cancer Institute (U01CA235507)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U24DK133658)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD106463)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords
mass spectrometry data processing, ion mobility spectrometry, mass spectrometry imaging, hybrid dataset, spatial metabolomics, spectral annotation, data analysis software
MeSH terms
Software, Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review